Skip to main content
Clinical Trials/NCT01630291
NCT01630291CompletedNot Applicable

A Non-Randomized, Open-Label Study to Determine the Effect of Electrical Stimulation on Tear Production

Oculeve, Inc.1 site in 1 country4 target enrollmentStarted: July 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
4
Locations
1
Primary Endpoint
Schirmer Score

Study Overview

Brief Summary

The purpose of this study is to investigate whether electrical stimulation of the nerve innervating the tear gland results in tear production in subjects with severe Dry Eye.

Detailed Description

A non-randomized, open-label study designed to investigate the feasibility of a novel treatment for severe Dry Eye Disease, which involves safe delivery of small electrical currents to the lacrimal nerve to induce tear production.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Schirmer test with topical anesthesia of ≤ 5 mm/5 min in at least one eye
  • •Sum of corneal and interpalpebral conjunctival staining of > +5 in the same eye where corneal staining is > +2 using the CLEK criteria.

Exclusion Criteria

  • •Individuals with the presence or history of any ocular disorder or condition (including ocular surgery, trauma, and disease) that could possibly interfere with the interpretation of the study results. Individuals who have had LASIK or other refractive surgeries are eligible. Excluded conditions include:
  • •History of orbital trauma
  • •History of orbital surgery
  • •Orbital cancer
  • •History of orbital cancer
  • •Within the 3 months before the Screening Visit, known history of ocular infection (viral, bacterial, fungal), inflammation not associated with dry eye, or active ocular herpes

Arms & Interventions

Electrical stimulation

Experimental

Intervention: Electrode device (Device)

Outcomes

Primary Outcomes

Schirmer Score

Time Frame: Up to 16 days

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials